Steroid molecules have a long history of incorporation into silicone elastomer materials for controlled release drug delivery applications. Previously, based on in vitro release testing and drug content analysis, we demonstrated indirectly that the contraceptive progestin levonorgestrel (LNG) chemically and irreversibly binds to addition cure silicone elastomers, presumably via a hydrosilylation reaction between the levonorgestrel ethynyl group and the hydrosilane groups in the poly(dimethylsiloxane-co-methylhydrosiloxane) crosslinker of the silicone elastomer. Here, for the first time, we report that solid state 13 C nuclear magnetic resonance (NMR) spectroscopy provides direct evidence for the irreversible binding of ethinyl estradiol (EE) -an estrogenic steroid molecule also containing an ethynyl functional group -to an addition cure silicone elastomer. By preparing silicone elastomer samples containing 13 C-labelled EE, signals in the NMR spectra could readily be assigned to both the free and bound EE. Additional depolymerisation studies, performed on an addition cure silicone elastomer system from which the unbound EE fraction was completely extracted, further confirmed the presence of bound EE through the formation of coloured reaction mixtures resulting from the reaction of bound EE and trifluoroacetic acid (TFA). These methods will be particularly useful in the ongoing development of new steroidreleasing silicone drug delivery devices, including various vaginal ring devices for contraception, HIV prevention and multipurpose prevention technology applications.
Introduction
Following first demonstration in 1966 that steroid molecules could permeate through the walls of silicone rubber devices implanted subdermally in ewes (Dziuk and Cook, 1966) , a number of steroid-releasing silicone elastomer controlled release drug delivery devices have since reached market, including the subdermal implants Norplant®, Norplant II® and Jadelle® (Croxatto, 2002) , the levonorgestrel-releasing intrauterine device Mirena® (Rose et al., 2009; Mansour, 2012) , and the vaginal ring products Estring®, Femring®, Progering® and Fertiring® (Ballagh, 2004; Friend, 2015; Nath and Sitruk-Ware, 2010; Merkatz et al., 2009; Buckler and Al-Azzawi, 2003; Al-Azzawi and Buckler, 2003) . Several new silicone elastomer vaginal rings are currently in development, including a dapivirine (DPV)-releasing ring for prevention of infection with the human immunodeficiency virus (HIV) (Baeten et al., 2016; Nel et al. 2016 Nel et al. , 2009 Malcolm et al., 2016; McCoy et al., 2017) , a combination dapivirine/maraviroc vaginal ring for HIV prevention (Fetherston et al., 2013; Chen et al., 2015) , a dapivirine/levonorgestrel (LNG) ring for combination HIV prevention and contraception (Boyd et al., 2016; Murphy et al., 2016) , a combination anastrozole/LNG ring as a novel therapy for treatment of endometriosis (Reinecke et al., 2016; Rotgeri et al., 2015; Schultze-Mosgau et al., 2016) , a vaginal ring releasing the progesterone receptor modulator ulipristal acetate for contraception (Huang et al., 2014; Brache et al., 2012) , and a Nestorone® (NES; segesterone acetate)/ethinyl estradiol (EE) ring for combination contraception (Weisberg et al., 2005; Fraser et al., 2005; Sivin et al., 2005; Croxatto et al., 2006; Jensen et al., 2018; Merkatz et al., 2014; Stifani et al., 2018) . Given the limited choice of medical grade polymers for long-term human implantation, silicone elastomers will likely remain an important material for development of controlled release drug delivery devices (Mashak and Rahimi, 2009; Kleiner et al., 2014; Malcolm et al., 2016) .
Recently, as part of preclinical development of the DPV/LNG vaginal ring, we reported the irreversible binding of LNG, but not DPV, in the addition cure silicone elastomer material used to construct the ring, resulting in a reduction in the content assay value of LNG and impacting LNG in vitro release (Murphy et al., 2016; Boyd et al., 2016) . Despite a lack of direct evidence, we hypothesized that the binding involved a hydrosilylation reaction between the LNG ethynyl group (C^C) and the hydrosilane (SieH) functionalised polydimethylsiloxane molecules within the elastomer system (Lidegaard et al., 2012; Lewis et al., 1991) , rendering the LNG covalently attached to the elastomer and incapable of release (Murphy et al., 2016) . During the normal silicone elastomer curing process, these hydrosilane groups react with vinyl-functionalised (SieCH]CH 2 ) polydimethylsiloxane molecules (Fig. 2) . The degree of LNG binding could be reduced through modification of the silicone cure temperature and time and by using larger LNG particles (Murphy et al., 2016) . However, direct evidence for the covalent binding reaction could not be confirmed using nuclear magnetic resonance (NMR) analysis as the bound LNG fraction in the silicone elastomer was below the level of detection.
The NES/EE vaginal ring, currently under development by the Population Council (New York, USA), comprises a silicone elastomer ring body into which two steroid-containing silicone elastomer cores are inserted -one core contains only NES and the second both NES and EE (Fig. 1) . The drug-free rate-controlling ring body is manufactured from an addition cure silicone elastomer while the drug-loaded cores are prepared using a condensation cure silicone elastomer (Fig. 1A) . Other drug delivery devices are similarly constructed using both drugloaded silicone elastomer cores and drug-free silicone elastomer sheaths, such as the LNG-releasing Mirena® intrauterine device (Robertson and Braun 1982) and the Jadelle® subdermal implant (Sivin et al., 2001; Croxatto, 2002) . The condensation and addition cure chemistries of these silicone elastomer systems are very different. Condensation cure silicones are often preferred for incorporation of drugs due to their greater compatibility with a wider range of chemical functional groups than addition cure systems (Malcolm et al., 2016) .
However, the condensation cure reaction produces propanol (or other volatile alcohols) as a reaction by-product, which has a tendency to dissolve the incorporated drug and lead to a large initial burst of release (Malcolm et al., 2012) . In contrast, addition cure silicone elastomer systems, which do not produce any alcoholic reaction product, are susceptible to deactivation of the platinum catalyst by certain chemical functional groups leading to inhibition of cure (Jerschow, 2001) . During stability testing of the NES/EE vaginal ring, a lower-than-expected content assay value for the EE component in the ring device was measured, similar to that observed previously for the LNG component in the DPV/LNG ring. It is notable that both EE and LNG contain the same ethynyl functional group appended to the same carbon of the D ring of the steroid structure. Since EE could be fully recovered via solvent extraction from NES + EE cores that had not yet been assembled into rings (even after long term storage), the reduced EE assay value was tentatively attributed to a hydrosilylation reaction between EE and the hydrosilane groups in the addition cure silicone elastomer ring body upon molecular permeation of EE through the ring body; the same reaction as reported previously for LNG in the DPV/LNG ring. To date, no direct evidence for this reaction has been reported.
Here, we report that solid state 13 C nuclear magnetic resonance spectroscopy ( 13 C-ssNMR) provides the first direct evidence for irreversible binding of EE to an addition cure silicone elastomer. By preparing silicone elastomer samples containing 13 C-labelled ethinyl estradiol (specifically, the ethynyl carbons are labelled and are therefore particularly sensitive to any reaction at this site), signals in the 13 CssNMR spectra could readily be assigned to both the free and bound steroid.
Materials and methods

Materials
Addition cure silicone elastomer systems DDU-4331 (also known as MED4-4224) and DDU-4320 were supplied by NuSil™ Technology LLC (Carpinteria, CA, USA % D), acetone and trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich (Gillingham, UK).
Manufacture of silicone elastomer samples
DDU-4331 silicone elastomer mixes without EE were prepared by intimately mixing DDU-4331 Part A and DDU-4331 Part B (9:1) in a DAC150 FVK-Z Speedmixer™ (3000 rpm, 30 s). DDU-4320 elastomer mixes without EE were similarly prepared by mixing DDU-4320 Part A and Part B in the required 1:1 ratio. EE-loaded (2% w/w) DDU-4331 and DDU-4320 silicone elastomer mixes were similarly prepared except with extended speedmixing at 3000 rpm for 60 s to achieve a dispersion of the drug powders in the silicone elastomer. The elastomer mixes were poured onto glass plates fitted with a cellulose acetate release liner and 1 mm spacers. After pouring, a second acetate release liner and glass plate were set on top and the mixtures compressed to form thin viscous films. Non-medicated DDU-4331 and DDU-4320 silicone elastomer samples were cured in an oven at 150°C for 10 min and 90°C for 10 min, respectively. EE-13 C 2 -loaded DDU-4320 samples were cured in an oven at 90°C for 30 min. Despite adjustments to the cure conditions (final temperature 130°C for > 20 h), both the EE-13 C 2 and EEloaded DDU-4331 silicone samples only partly cured to form gum-like consistency materials due to EE inhibition of the curing reaction.
Solvent extraction of EE from cured silicone elastomer samples
In order to increase detection sensitivity for any bound EE using 13 CssNMR, the non-bound EE fraction was extracted from the silicone elastomer samples. Elastomer samples were placed in individually labelled glass vials. CDCl 3 or acetone (10-40 mL, depending on EE loading) was added to each extraction flask. Flasks were sealed and stored at ambient temperature for 24 h with periodic manual shaking. This extraction protocol was repeated three times using fresh volumes of solvent to ensure complete extraction of the non-bound EE. The elastomer samples were removed from the solvent and dried overnight by solvent evaporation in preparation for 13 C-ssNMR analysis.
Extraction solutions were also retained for solution-state NMR analysis to verify that extraction of the non-bound EE fraction had occurred.
Trifluoroacetic acid depolymerisation of cured silicone elastomers
Silicone elastomers are depolymerised via hydrolysis when exposed to acids to form low viscosity colloidal liquids. Also, under highly acidic conditions, steroid compounds are known to react to form deeply coloured complexes (Linford, 1957) . DDU-4331 and DDU-4320 silicone elastomer samples (∼0.2 g) -with (2% w/w) and without EE -were placed in individual glass vials. TFA (10 mL) was added and the flasks immediately sealed. After 24 h, any colour change was noted and photographed. The colour intensity of the depolymerised samples was used to determine whether EE or EE-13 C 2 was detectable pre-and postsolvent extraction. The sensitivity of the TFA assay was determined using a series of EE-loaded DDU-4331 silicone elastomer samples (0.01%, 0.05%, 0.1%, 0.2%, 0.5%, 1.0% and 2.0% w/w). A nonmedicated DDU-4331 silicone sample and a sample of EE powder (as supplied) were used as study controls.
NMR analysis
Various solution-state and solid-state 1 H NMR and 13 C NMR experiments were conducted to investigate binding of EE and EE-13 C 2 to DDU-4331 and DDU-4320 addition-cure silicone elastomer systems. In order to aid interpretation of the measured NMR spectra, MarvinSketch NMR Predictor software (ChemAxon, Budapest, Hungary) was used to produce simulated NMR spectra for EE, a model addition cure silicone elastomer and the reaction product for EE covalently bound to the silicone elastomer. C NMR analysis, samples were dissolved, dispersed or swollen in CDCl 3 . Spectra were recorded using a Bruker DPX 400 MHz NMR spectrometer (Bruker UK Ltd., Coventry, UK). Chemical shifts were recorded in parts per million (ppm) with the chemical shift of the internal reference set to 77.0 ppm for 13 C NMR and 
Solution-state NMR analysis
Solid-state NMR analysis (ssNMR)
Solid-state NMR experiments were performed at the EPSRC National Solid-State NMR Service at Durham University.
13
C NMR experiments were performed using either a Bruker Avance III HD spectrometer with a 4 mm (rotor o.d.) magic angle spinning (MAS) probe or a Varian VNMRS spectrometer with a 6 mm (o.d.) rotor operating at 100.6 MHz. Bruker Avance 13 C NMR spectra were obtained using total suppression of spinning sidebands (TOSS) and cross-polarisation (CP) with a 4 or 10 s recycle delay, 1 or 4 ms contact time, ambient probe temperature (∼25°C) and a sample spin-rate of 8 kHz. Between 250 and 20,000 repetitions were accumulated depending on the sample being analysed. 13 C NMR reference spectra (EE, EE-13 C 2 and DDU-4331) were obtained using the Varian VNMRS spectrometer with TOSS (except for the EE API sample) and CP, a 1 or 30 s recycle delay, 1 or 5 ms contact time, ambient probe temperature and a spin-rate of 6 kHz. The number of scans accumulated for EE, EE-13 C 2 and DDU-4331 NMR samples varied (72, 116 and 992 repetitions) depending on the sample being analysed.
Results and discussion
To aid understanding of the reduced EE content values measured during long-term stability investigation of the NES/EE vaginal ring, a series of NMR studies were performed on supplied materials (APIs and silicone elastomer components) and cured silicone elastomer samples (with and without API) to seek direct evidence for binding of EE to the DDU-4331 silicone elastomer. We used 13 C-labelled EE to improve the chances of detecting bound EE using 13 C NMR, which would otherwise be very difficult given the low natural abundance of the 13 C isotope (1.1%) coupled with the relatively low fraction of EE that actually binds to the DDU-4331 silicone elastomer system.
Sample preparation
The 2% w/w EE and EE-13 C 2 loaded DDU-4331 silicone samples were tacky due to partial cure, presumably due to partial inhibition of the silicone curing reaction by the EE. These issues could not be resolved by reducing the EE loading or altering the cure temperature and time. Even greater inhibition of cure was observed with the EE-13 C 2 material. Interestingly, incorporation of either 2% w/w labelled or unlabelled EE into the alternative addition cure silicone elastomer DDU-4320 -previously used for manufacture of DPV/LNG vaginal rings, where the LNG had a strong tendency to bind to the silicone elastomer -did not show any obvious inhibition of cure, likely due to different formulation characteristics between DDU-4331 and DDU-4320.
NMR analysis
13 C NMR modelling software predicted that the reaction product between EE and a model addition cure silicone elastomer would contain new vinylene carbons (eCH]CHe) with chemical shifts in the 120-140 ppm range and disappearance of the ethynyl signals at ∼74 and 100 ppm (Fig. 3) . Signals associated with the aromatic carbons are also expected to appear in 110-140 ppm region whilst the CeOH groups are predicted to appear at ∼80 and 155 ppm. It should be noted that these predicted chemical shifts do not take into account the different modes of stereochemical addition of the EE terminal alkyne group (i.e. syn-, anti-and α-adducts) to the hydrosilanes of the silicone and were only intended to be indicative (Yong et al., 2006) .
Solution-state NMR reference spectra
Solution-state 13 C NMR spectra for EE, EE-13 C 2 and DDU-4331 silicone elastomer in CDCl 3 were recorded to identify reference signals. In all three solution-state 13 C NMR reference spectra (Fig. 4A-C) , the triplet signal observed close to 77 ppm is due to the CDCl 3 solvent. In the EE 13 C NMR reference spectra (Fig. 4B) 
Solid-state NMR (ssNMR) reference spectra
13
C-ssNMR reference spectra were recorded for non-medicated cured DDU-4331 silicone elastomer, EE and EE-13 C 2 (Fig. 4D-F , respectively). The narrow signals observed for the EE reference material (Fig. 4B ) are typical of crystalline molecules. Spinning side bands have not been suppressed in this spectrum. Broader peaks observed in the EE-13 C 2 spectrum (Fig. 4F) , particularly for the labelled ethynyl groups at 75 and 85 ppm, are due to strong interactions between the two neighbouring 13 C atoms (Booy et al., 2005) . As previously observed with the solution-state spectrum, the 13 C-ssNMR reference spectrum for the cured DDU-4331 elastomer displayed a single large (SieCH 3 ) signal at 1.3 ppm (Fig. 4D ).
Subtle differences in 13 C-ssNMR spectra for the labelled and unlabelled EE materials were observed when spectra were overlaid (overlaid spectra not shown). We suspect that these spectral differences may be the result of different polymorphic forms of EE. EE is known to exist in at least two polymorphic forms with melting points at 146°C and 183°C as well as multiple pseudo-polymorphs in the form of solvates and hydrates (Veronez et al., 2015; Guguta et al., 2008; Pheasant, 1950) . As the EE and EE-13 C 2 used in this study were obtained from two different suppliers (characterisation information was not provided), it is possible that differences in the synthetic processes caused the formation of different crystalline forms.
3.5. NMR spectra of silicone elastomer samples containing EE or EE-
C 2
Solvent extraction was performed on unlabelled EE-loaded silicone elastomer samples to remove the non-bound EE fraction prior to 13 CssNMR analysis. Solution-state 1 H and 13 C NMR analysis of the resulting extraction solutions showed a spectrum consistent with the chemical structure of EE (spectra not shown), confirming successful extraction of the non-bound EE portion.
13
C-ssNMR analysis of EE-loaded DDU-4331 samples (pre-and post-extraction) proved inconclusive, i.e. no new signals suggestive of newly formed bonds were observed. However, as previously discussed, incorporation of EE into DDU-4331 resulted in inhibition of cure, with the 13 C-labelled EE samples curing to a lesser extent than the unlabelled EE samples prepared with the same loading. This is almost certainly due to the influence of particle size on drug solubility in the silicone, as noted previously for LNG (Murphy et al., International Journal of Pharmaceutics 548 (2018) 689-697 2016). Unfortunately, it was not possible to measure the particle size of 13 C-labelled EE due to limited amount of material and its cost. C 2 or DDU-4331 reference spectra ( Fig. 4F and D, respectively) and are attributed to newly-formed vinylene carbons produced from the hydrosilylation reaction between the ethynyl groups of the EE-13 C 2 and the hydrosilane groups within the silicone elastomer (Fig. 2) . Analysis of the EE-13 C 2 + DDU-4331 material following acetone extraction showed that the ethynyl signals (75 and 87 ppm) associated with the non-bound EE-13 C 2 were no longer visible in the post-extraction sample (Fig. 5B) , confirming that the non-bound EE-13 C 2 fraction had been successfully removed via solvent extraction. More interestingly, the new vinylene signals at 125 and 153 ppm were still observed and showed no reduction in intensity when compared to the non-extracted sample (Fig. 5A) , clearly indicating that they could not be removed from the silicone elastomer by solvent extraction and therefore must be attributed to bound EE. Therefore, Fig. 5A and B provide direct evidence for the formation of the irreversible covalent bond between the ethynyl groups of the EE-13 C 2 and the hydrosilane groups of the DDU-4331 addition cure silicone elastomer. In addition to the DDU-4331 system, EE-13 C 2 loaded samples (2% w/w) were manufactured using DDU-4320 addition cure silicone elastomer. DDU-4320 has previously been used to successfully manufacture a vaginal ring device containing DPV and LNG. LNG is a contraceptive steroid that also has a tendency to bind to addition cure silicones (Murphy et al., 2016; Boyd et al., 2016) . With this material, however, no inhibition of cure was observed.
13 C-ssNMR spectra for the EE-13 C 2 + DDU-4320 elastomer samples showed intense 13 C-labelled ethynyl carbons signals at 76 and 88 ppm (spectra not shown). However, no new signals indicative of EE-13 C 2 binding were observed. In fact, no EE-
C 2 associated signals were observed in the spectrum of the silicone material after solvent extraction, indicating that the non-bound Fig. 3 . Simulated 13 C NMR spectra for ethinyl estradiol and platinum-catalysed hydrosilylation reaction product between ethinyl estradiol and a model methylhydrosilane molecule. International Journal of Pharmaceutics 548 (2018) 689-697 drug fraction had been successfully extracted and that any bound EE-
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C 2 was below the limits of detection. On reflection, the lack of curing issues observed with the EE-13 C 2 + DDU-4320 silicone elastomer indicated that the fraction of EE bound to the DDU-4320 was sufficiently low so as not to inhibit the curing reaction and therefore too low for detection by ssNMR. This reduced propensity for binding is most likely due to formulation differences between the silicone elastomer systems, and particularly the concentration of reactive silane (SieH) groups present.
Depolymerisation with trifluoroacetic acid
To supplement the NMR analysis, silicone elastomer depolymerisation experiments were performed using TFA as a qualitative measure of the presence of EE in the cured silicone elastomer samples. TFA depolymerisation of steroid-containing silicone elastomer samples produces deeply coloured, low viscosity colloidal liquids, with the colour due to reaction between the steroid and TFA (Linford, 1957) . The sensitivity of the TFA assay was determined using a series of EEloaded (0.01%, 0.05%, 0.1%, 0.2%, 0.5%, 1.0% and 2.0% w/w) DDU-4331 silicone elastomer samples. A small sample of each EE-loaded silicone was added to a known volume of TFA. A sample of EE (as supplied) and a non-medicated DDU-4331 silicone sample were used as controls. The colour intensity of the EE + TFA reaction products, noted after 24 h, was shown to be dependent on the initial EE concentration.
No coloured reaction product could be detected for samples containing 0.01% w/w EE but colour was detected for samples containing 0.05% w/w EE. Therefore, the lower limit of detection was determined to be between 0.01% w/w and 0.05% w/w of EE. Although, only qualitative in nature, the TFA depolymerisation studies appeared to be more sensitive to the presence of the EE than either solution-state or solid-state 13 C NMR and provide a valuable resource for detection of residual bound EE. Depolymerisation studies were performed on a range of EE and EE-13 C 2 loaded silicone elastomer samples, both before and after solvent extraction, as a means of visually identifying the presence of bound EE. TFA depolymerisation solutions obtained from a series of DDU-4331 and DDU-4320 elastomer samples, with and without EE-13 C 2 , are shown in Fig. 6A & B. Depolymerisation of a non-medicated DDU-4331 control sample produced a brilliant white solution (Fig. 6A ). This white colour is attributed to the titanium dioxide (TiO 2 ) re-enforcing filler used in this particular silicone material. Addition of a 2% w/w EE-13 C 2 + DDU-4331 silicone elastomer samples to TFA produced a deep red-brown solution indicative of the presence of a large quantity of EE-13 C 2 (bound and non-bound) (Fig. 6A) . Interestingly, despite extensive solvent extraction with multiple large volumes of acetone, depolymerisation of the extracted EE-13 C 2 + DDU-4331 silicone material produced a coloured solution that was only slightly paler than that of the pre-extraction sample. This suggested that a large proportion of EE-13 C 2 was still present in the silicone elastomer, and presumably in the bound state. These results strongly support the findings of the 13 Css-NMR experiments (Fig. 5) . A similar trend was observed for the unlabelled EE + DDU-4331 silicone samples (image not shown) despite the fact that solid-state NMR analysis of this material proved Fig. 5 . A -solid-state 13 C NMR spectrum of a 2% w/w EE-13 C 2 + DDU-4331 silicone elastomer sample before acetone solvent extraction; B -solid-state 13 C NMR spectrum of a 2% w/w EE-13 C 2 + DDU-4331 silicone elastomer sample after acetone solvent extraction.
inconclusive. The coloured reaction products obtained for a non-medicated DDU-4320 silicone elastomer sample, an EE-13 C 2 + DDU-4320 sample preextraction and two EE-13 C 2 + DDU-4320 silicone elastomer samples extracted in either CDCl 3 or acetone are shown in Fig. 6B . The image shows an off-white solution for the non-medicated DDU-4320 elastomer sample, an amber coloured solution for the EE-13 C 2 + DDU-4320 sample and pale orange coloured solutions for both the acetone and CDCl 3 extracted EE-13 C 2 + DDU-4320 samples. The paler solutions observed for the CDCl 3 and acetone extracted samples suggest that although a fraction of the non-bound drug had been removed during the extraction process, a detectable fraction of EE-13 C 2 still remained either in the bound or unbound state. As mentioned previously, no evidence of EE-13 C 2 was observed in the 13 Css-NMR spectra obtained for this extracted silicone material (spectra not shown) indicating that the nonbound drug fraction had been removed and any bound drug was below the limits of detection. These findings suggest that the TFA colour indicating assay is particularly sensitive to the presence of low levels of steroids when compared to either solution-state or solid-state NMR.
Conclusions
In this study, we provide for the first time direct evidence for the covalent and irreversible binding of a contraceptive steroid to an addition cure silicone elastomer system. Using 13 C-ssNMR analysis of DDU-4331 silicone elastomer samples containing EE-13 C 2 , we observed NMR signals due to the 13 C-labelled ethynyl groups (75 and 87 ppm) as well as additional signals associated with newly formed 13 C-labelled vinylene carbons (125 and 153 ppm). These new signals -not observed in the EE or silicone elastomer reference spectra -indicated the formation of a new C]C bond resulting from the hydrosilylation reaction between the EE-13 C 2 and the silicone elastomer. In order to confirm that these new signals resulted from bound EE, the elastomer samples were subjected to acetone extraction. Analysis of the extracted elastomer samples showed the complete disappearance of the ethynyl-associated signals but no reduction in the new vinylene signals, indicating that they could not be removed by the solvent extraction process and therefore must be bound. These new vinylene chemical shifts provide conclusive evidence for covalent and irreversible binding of EE-13 C 2 to the hydrosilane groups of the DDU-4331 addition cure silicone elastomer system. These results were further confirmed by the findings of a TFA depolymerisation assay that demonstrated formation of strongly coloured reaction products in the presence of bound EE.
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